SAN DIEGO, April 23 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. announced today that the Company will report its first quarter 2007 financial results after the Nasdaq market closes on Thursday, May 3, 2007. A live conference call and webcast will be held at 5:00 p.m. Eastern Daylight Time (2:00 p.m. Pacific Daylight Time).
Participants can access the live conference call by dialing 1-866-314-4483 (US) or 617-213-8049 (International) using the conference passcode 32725628. The call can also be accessed via the webcast through the Company’s website at http://www.neurocrine.com
If you are unable to attend the Webcast and would like further information on this announcement please contact the Investor Relations Department at Neurocrine Biosciences at (858) 617-7600. A replay of the Conference Call will be available approximately one hour after the conclusion of the call by dialing 1-888-286-8010 (US) or 617-801-6888 (International) using the passcode 87604493. The call will be archived for two weeks.
Neurocrine Biosciences, Inc. is a product-based biopharmaceutical company focused on neurological and endocrine diseases and disorders. The product candidates address some of the largest pharmaceutical markets in the world including insomnia, anxiety, depression, irritable bowel syndrome, endometriosis and CNS related disorders. Neurocrine Biosciences, Inc. news releases are available through the Company’s website via the Internet at http://www.neurocrine.com
Neurocrine Biosciences, Inc.
CONTACT: Elizabeth Foster of Neurocrine Biosciences, Inc., +1-858-617-7600
Web site: http://www.neurocrine.com/
